Chromadex Corp Stock
Chromadex Corp Stock
Chromadex Corp gained 0.630% compared to yesterday.
We see a rather positive sentiment for Chromadex Corp with 11 Buy predictions and 1 Sell predictions.
With a target price of 5 € there is a hugely positive potential of 58.23% for Chromadex Corp compared to the current price of 3.16 €.
Our community identified positive and negative aspects for Chromadex Corp stock for the coming years. 0 users see the criterium "EBIT Margin" as a plus for the Chromadex Corp stock. On the other hand our users think that "EBIT Margin" could be a problem in the future.
Pros and Cons of Chromadex Corp in the next few years
Pros
?
S********** s********
?
G***** c******* t* c**********
?
C******** o* t** e**********
Cons
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Chromadex Corp vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Chromadex Corp | 0.630% | -9.714% | -17.277% | 135.821% | 135.821% | -42.545% | - |
Organovo Holdings Inc. | 1.250% | -1.682% | -8.071% | -47.422% | -14.522% | -84.011% | -94.977% |
Intellia Therapeutics Inc | 1.440% | 6.990% | 3.241% | -41.001% | -18.584% | -52.220% | 65.869% |
VBI Vaccines Inc. | 2.990% | 5.176% | 2.893% | -79.894% | 7.358% | -99.214% | -98.935% |
Comments
ChromaDex Co. (NASDAQ: CDXC) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock.
Show more
Ratings data for CDXC provided by MarketBeat
ChromaDex Co. (NASDAQ: CDXC) had its price target raised by analysts at Roth Mkm from $4.25 to $6.00. They now have a "buy" rating on the stock.
Show more
Ratings data for CDXC provided by MarketBeat
ChromaDex Co. (NASDAQ: CDXC) is now covered by analysts at StockNews.com. They set a "strong-buy" rating on the stock.
Show more
Ratings data for CDXC provided by MarketBeat